We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Mary Cianfrocca,

Medical Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Breast Oncology
Medical Oncology
Education
Medical school:
Board Certifications

  • 2009, Subspeciality Recertification: Oncology

  • 1999, American Board of Internal Medicine, Subspeciality Certification: Oncology

  • 1993, American Board of Internal Medicine Diplomate

Degrees

  • 2017, Masters of Business Administration, W.P. Carey School of Business, Arizona State University, Tempe, Arizona

  • 1989, Doctor of Osteopathy, Valedictory Honors Distinction, Chicago College of Osteopathic Medicine, Downers Grove, Illinois

  • 1984, Loyola University, Chicago, Illinois

Fellowship

  • 1996-1999, Hematology/Oncology Fellowship, Department of Medicine, Northwestern University, Chicago, Illinois

Residency

  • 1993-1994, Chief Resident, Rush Presbyterian St. Luke’s Medical Center, Chicago, Illinois

  • 1990-1993, Resident, Department of Internal Medicine, Rush Presbyterian, St. Luke’s Medical Center, Chicago, Illinois

Internship

  • 1989-1990, Rotating Internship, Chicago Osteopathic Hospital, Chicago, Illinois

Professional Experience

  • 2019-present, Associate Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California

  • 2019-present, Senior Medical Director, Community Practices, City of Hope, Duarte, California

  • 2018-2019, Oncology Physician Executive, Northwest Region

  • 2016-2018, Regional Medical Director, Northwest Region, Banner MD Anderson Cancer Center, Gilbert, Arizona

  • 2014-2019, Division Chief, Internal Medicine, Banner MD Anderson Cancer Center, Gilbert, Arizona

  • 2012-2019, Medical Director, Clinical Cancer Genetics Program, Banner MD Anderson, Gilbert, Arizona

  • 2011-2019, Director, Multidisciplinary Breast Program, Banner MD Anderson, Gilbert, Arizona

  • 2011-2019, Additional Clinical Stewardship, Banner MD Anderson, Gilbert, Arizona

  • 2004-2011, Breast Medical Oncologist, Northwestern University Feinberg School of Medicine, Chicago, Illinois

  • 1999-2004, Breast Medical Oncologist, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia

Academic Appointments
  • Professor, Department of Medical Oncology & Therapeutics Research
  • Senior Medical Director, Community Practices
About Me
My career has been dedicated to breast cancer and I've been most passionate about research to find better treatments and ultimately a cure.
 
Mary Cianfrocca, D.O., M.B.A., brings over 20 years of clinical, research and administrative expertise to City of Hope, where she serves as senior medical director of community practices.
 
A longtime expert in the research and treatment of breast cancer, Dr. Cianfrocca strives to bring her patients the best possible care while exploring the newest and most innovative treatments on the horizon, from targeted therapy to immunotherapy and much more.
 
Dr. Cianfrocca received her medical degree at Chicago College of Osteopathic Medicine and continued her training at Chicago’s Rush Presbyterian St. Luke’s Medical Center and Northwestern University. She also holds an M.B.A. from Arizona State University.
 
Dr. Cianfrocca joined City of Hope following nearly a decade in leadership roles at Banner MD Anderson Cancer Center in Arizona. She is passionate about raising public awareness of breast cancer prevention and early detection. She is a much sought-after spokesperson in the mass media.
 
Dr. Cianfrocca ardently believes in City of Hope’s multidisciplinary approach to cancer care, and she admires the “spirit of collaboration and teamwork, with the goal of providing the best and most compassionate care for all of our patients and their loved ones.”
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.